Desvenlafaxine extended release.

Suppr

超能文献

作者信息

Yang Lily P H, Plosker Greg L

机构信息

Wolters Kluwer Health | Adis, Auckland, New Zealand.

出版信息

CNS Drugs. 2008;22(12):1061-9. doi: 10.2165/0023210-200822120-00008.

DOI:10.2165/0023210-200822120-00008

PMID:18998743

Abstract

摘要

相似文献

Desvenlafaxine extended release.

CNS Drugs. 2008;22(12):1061-9. doi: 10.2165/0023210-200822120-00008.

Desvenlafaxine for depression.

Med Lett Drugs Ther. 2008 May 19;50(1286):37-9.

Clinical utility of desvenlafaxine 50 mg/d for treating MDD: a review of two randomized placebo-controlled trials for the practicing physician.

Curr Med Res Opin. 2010 Jan;26(1):139-50. doi: 10.1185/03007990903408678.

Desvenlafaxine: a new serotonin-norepinephrine reuptake inhibitor for the treatment of adults with major depressive disorder.

Clin Ther. 2009 Jun;31 Pt 1:1374-404. doi: 10.1016/j.clinthera.2009.07.012.

Desvenlafaxine 50 and 100 mg/d in the treatment of major depressive disorder: an 8-week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group trial and a post hoc pooled analysis of three studies.

Clin Ther. 2009 Jun;31 Pt 1:1405-23. doi: 10.1016/j.clinthera.2009.07.006.

A randomized, double-blind, placebo-controlled trial of desvenlafaxine succinate in adult outpatients with major depressive disorder.

J Clin Psychiatry. 2007 Nov;68(11):1663-72. doi: 10.4088/jcp.v68n1105.

New drugs: Etravirine, sinecatechins, and desvenlafaxine succinate.

J Am Pharm Assoc (2003). 2008 May-Jun;48(3):428-31. doi: 10.1331/JAPhA.2008.08518.

Desvenlafaxine succinate for the treatment of major depressive disorder.

Expert Opin Pharmacother. 2008 Aug;9(12):2129-36. doi: 10.1517/14656566.9.12.2129.

Antidepressant "treatment".

Menopause. 2010 Jul;17(4):672-5. doi: 10.1097/gme.0b013e3181e15e0e.

Desvenlafaxine succinate: a newer antidepressant for the treatment of depression and somatic symptoms.

Postgrad Med. 2010 Jan;122(1):125-38. doi: 10.3810/pgm.2010.01.2106.

引用本文的文献

Clinically significant drug interactions with newer antidepressants.

CNS Drugs. 2012 Jan 1;26(1):39-67. doi: 10.2165/11594710-000000000-00000.

Pharmacological and clinical profile of newer antidepressants: implications for the treatment of elderly patients.

Drugs Aging. 2010 Aug 1;27(8):625-40. doi: 10.2165/11537140-000000000-00000.

本文引用的文献

An assessment of drug-drug interactions: the effect of desvenlafaxine and duloxetine on the pharmacokinetics of the CYP2D6 probe desipramine in healthy subjects.

Drug Metab Dispos. 2008 Dec;36(12):2484-91. doi: 10.1124/dmd.108.021527. Epub 2008 Sep 22.

Efficacy, safety, and tolerability of fixed-dose desvenlafaxine 50 and 100 mg/day for major depressive disorder in a placebo-controlled trial.

Int Clin Psychopharmacol. 2008 Sep;23(5):243-53. doi: 10.1097/YIC.0b013e32830cebed.

Efficacy, safety, and tolerability of desvenlafaxine 50 mg/day and 100 mg/day in outpatients with major depressive disorder.

Curr Med Res Opin. 2008 Jul;24(7):1877-90. doi: 10.1185/03007990802161923. Epub 2008 May 27.

Major depressive disorder.

N Engl J Med. 2008 Jan 3;358(1):55-68. doi: 10.1056/NEJMra073096.

A randomized, double-blind, placebo-controlled trial of desvenlafaxine succinate in adult outpatients with major depressive disorder.

J Clin Psychiatry. 2007 Nov;68(11):1663-72. doi: 10.4088/jcp.v68n1105.

A randomized, double-blind, placebo-controlled trial of desvenlafaxine succinate in the treatment of major depressive disorder.

Int Clin Psychopharmacol. 2007 Nov;22(6):338-47. doi: 10.1097/YIC.0b013e3281e2c84b.

Safety and tolerability of antidepressants: weighing the impact on treatment decisions.

J Clin Psychiatry. 2007;68 Suppl 8:26-34.

Duloxetine: a review of its use in the treatment of major depressive disorder.

CNS Drugs. 2007;21(7):581-609. doi: 10.2165/00023210-200721070-00004.

A double-blind, placebo-controlled study of the efficacy and safety of desvenlafaxine succinate in the treatment of major depressive disorder.

J Clin Psychiatry. 2007 May;68(5):677-88. doi: 10.4088/jcp.v68n0504.

Desvenlafaxine succinate: A new serotonin and norepinephrine reuptake inhibitor.

J Pharmacol Exp Ther. 2006 Aug;318(2):657-65. doi: 10.1124/jpet.106.103382. Epub 2006 May 4.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验